FDA-cleared, post-intercourse vaginal health device launches

LiviWell Inc. has officially launched its FDA-cleared device, Livi, designed to absorb semen and other vaginal discharge after intercourse, according to an August 18, 2026 announcement from the company. The device will be available exclusively through LiviWell after initially receiving clearance from the FDA on March 24, 2026.^1,2

The clearance came after a formal submission process initiated on July 2, 2025, in which the company positioned Livi as a tool to support vaginal health by addressing post-intercourse symptoms such as odor and discharge. These symptoms are associated with temporary pH disruption caused by semen, which can promote conditions including bacterial vaginosis.¹

Livi is a single-use device constructed from soft polyurethane foam. It is inserted vaginally using a tampon-style applicator after intercourse to absorb semen and other post-intercourse fluids before being removed and discarded. The cleared labeling states the device absorbs fluids in approximately 60 seconds and may be used for up to 15 minutes following intercourse.¹

“Women have long shared frustrations around post-sex leakage and discomfort, said Michael Ingber, MD, co-founder and chief medical officer at LiviWell in the launch announcement. “Livi offers a simple, discreet option that fits naturally into a woman’s post-intimacy routine.”²

Clinical rationale and device design for Livi

The company noted that prior to Livi’s introduction, options for managing post-intercourse discharge and odor were limited, leaving a gap in intimate health care for a common and frequently underdiscussed concern.^1,2 The clinical rationale for the device is rooted in research into how semen affects vaginal pH, with pH disruption identified as a potential contributor to both symptoms and microbiome changes that may increase susceptibility to bacterial vaginosis.¹

"Conversations around post-sex vaginal health have historically been limited,” Ingber stated previously. “Achieving FDA clearance for Livi represents an important step toward bringing greater medical recognition and innovative solutions to women experiencing these everyday concerns."

References:

1. Fitch J. FDA clears LiviWell’s post-intercourse fluid absorption device to support vaginal health. Contemporary OB/GYN. Published March 24, 2026. Accessed August 18, 2026. https://www.contemporaryobgyn.net/view/fda-clears-liviwell-s-post-intercourse-fluid-absorption-device-to-support-vaginal-health
2. LiviWell Inc. Livi, the first FDA-cleared after-sex absorption device, is now available. PR Newswire. Published August 18, 2026. Accessed August 18, 2026. https://www.prnewswire.com/news-releases/livi-the-first-fda-cleared-after-sex-absorption-device-is-now-available